New England Guild Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,290
Closed -$209K 71
2022
Q1
$209K Buy
+1,290
New +$187K 0.11% 71

Other funds holding ABBV

New England Guild Wealth Advisors's ABBV Position: Q2 2022 in Review

New England Guild Wealth Advisors sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 1,290 shares — an estimated $209K sold.

New England Guild Wealth Advisors first reported a position in ABBV in Q1 2022 and held it in 1 quarter. The position peaked at $209K in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • New England Guild Wealth Advisors reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • New England Guild Wealth Advisors sold 1,290 AbbVie shares in Q2 2022, an estimated $209K.
  • New England Guild Wealth Advisors first reported a position in AbbVie in Q1 2022 and held it in 1 quarter.
  • New England Guild Wealth Advisors's AbbVie position peaked at $209K in Q1 2022.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on New England Guild Wealth Advisors's 13F filing for Q2 2022, filed 8 Jul 2022.